Loading chat...
NY A02646
Bill
Status
Introduced
1/26/2023
Primary Sponsor
Jacob Blumencranz
Click for details
AI Summary
- Prohibits doctors from prescribing antipsychotic, antidepressant, hallucinogen, or mood stabilizer drugs without prior written informed consent from the patient
- Requires notification to inform patients of any possible adverse effects of the prescribed psychiatric drug
- Requires disclosure of potential interactions between the psychiatric drug and any other medications the patient is currently taking
- Applies to both brand name and generic psychiatric drugs used to treat psychiatric disorders or conditions
- Takes effect immediately upon enactment
Legislative Description
Requires a doctor to obtain the informed consent of patients prior to prescribing psychiatric drugs notifying the patients of possible adverse effects of the drug.
Last Action
referred to higher education
1/3/2024
Committee Referrals
Higher Education1/26/2023
Full Bill Text
No bill text available